Pfizer Wins €1.9 Billion Covid Vaccine Case With Poland, Romania

Poland and Romania have been ordered by a Belgian court to pay Pfizer Inc. €1.9 billion ($2.2 billion) for Covid-19 vaccines ...

Belgian court orders Poland, Romania to buy $2.2 billion of Pfizer COVID vaccines

BRUSSELS, April 1 (Reuters) - A Belgian court on Wednesday ordered Poland and Romania to take delivery of 1.9 billion euros ...
24/7 Wall St.

High Yield vs. Sustainable Growth: Why AbbVie’s Dividend Beats Pfizer’s Despite the Lower Payout

Pharmaceutical companies AbbVie (NYSE:ABBV | ABBV Price Prediction) and Pfizer (NYSE:PFE) both reported fourth-quarter ...
PharmExec

Pfizer Receives Unsolicited Mini-Tender Offer for 1 Million Shares from Tutanota: Report

Tutanota offered $32 per Pfizer share for up to 1 million shares, expiring April 13, 2026, with plans to extend the bid until ...

Exclusive-Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles

By Bhanvi Satija LONDON, April 1 (Reuters) - Vaccine makers Pfizer and BioNTech halted a large U.S. trial of their updated ...

Pfizer Could Hit $36 by Year-End as Analysts See 2-to-1 Payoff on Key Prostate Cancer Trial

Pfizer (NYSE:PFE) has quietly built momentum in 2026, with shares up 6.61% year-to-date and 2.70% over the past year. The stock is currently trading near $26.84 but remains well below its 52-week high ...